Advanced NASH exhibited decreased ERRFI1 and increased EGFR expression, which supports the clinical importance of the MIG-6/EGFR axis in NASH-induced HCC development. Here, ERRFI1 is linked to metabolic dysfunction-associated steatohepatitis.